Matthew S. Davids, MD

    Matthew S. Davids, MD

    Associate Director of the Center for Chronic Lymphocytic Leukemia and an Assistant Professor of Medicine at Harvard Medical School
    • Is Chronic Lymphocytic Leukemia Curable With Newer Agents? Tuesday, August 14th, 2018

      Chronic lymphocytic leukemia (CLL) has long been considered an incurable disease. The goal of traditional frontline treatments is to minimize disease burden and allow patients to achieve durable remissions. However, with the advent of new targeted agents and immunotherapeutic options, investigators are devising new drug combinations that some believe may finally cure the disease. The [...]

    SHARE